Literature DB >> 19088281

Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells.

O Hantz1, R Parent, D Durantel, P Gripon, C Guguen-Guillouzo, F Zoulim.   

Abstract

The recently described hepatic cell line HepaRG is the sole hepatoma cell line susceptible to hepatitis B virus (HBV) infection. It provides a unique tool for investigating some unresolved issues of the virus' biology, particularly the formation of the viral mini-chromosome believed to be responsible for the persistence of infection. In this study, we characterized the main features of HBV infection: it is restricted to a subpopulation of differentiated hepatocyte-like cells that express albumin as a functional marker and represents around 10 % of all differentiated HepaRG cells. Infection may persist for more than 100 days in cells maintained at the differentiated state. Even though infected cells continued to produce infectious viral particles, very limited or no spreading of infection was observed. Low genetic variation was also observed in the viral DNA from viruses found in the supernatant of infected cells, although this cannot explain the lack of reinfection. HBV infection of HepaRG cells appears to be a very slow process: viral replication starts at around day 8 post-infection and reaches a maximum at day 13. Analysis of viral DNA showed slow and inefficient conversion of the input relaxed circular DNA into covalently closed circular (CCC) DNA, but no further amplification. Continuous lamivudine treatment inhibited viral replication, but neither prevented viral infection nor initial formation of CCC DNA. In conclusion, HBV infection in differentiated HepaRG cells is characterized by long-term persistence without a key feature of hepadnaviruses, the so-called 'CCC DNA amplification' described in the duck hepatitis B model.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19088281     DOI: 10.1099/vir.0.004861-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  60 in total

1.  Polo-like-kinase 1 is a proviral host factor for hepatitis B virus replication.

Authors:  Ahmed Diab; Adrien Foca; Floriane Fusil; Thomas Lahlali; Pascal Jalaguier; Fouzia Amirache; Lia N'Guyen; Nathalie Isorce; François-Loïc Cosset; Fabien Zoulim; Ourania Andrisani; David Durantel
Journal:  Hepatology       Date:  2017-11-06       Impact factor: 17.425

2.  Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions.

Authors:  Yuchen Xia; Arnaud Carpentier; Xiaoming Cheng; Peter Daniel Block; Yao Zhao; Zhensheng Zhang; Ulrike Protzer; T Jake Liang
Journal:  J Hepatol       Date:  2016-10-14       Impact factor: 25.083

3.  Complete replication of hepatitis B virus and hepatitis C virus in a newly developed hepatoma cell line.

Authors:  Darong Yang; Chaohui Zuo; Xiaohong Wang; Xianghe Meng; Binbin Xue; Nianli Liu; Rong Yu; Yuwen Qin; Yimin Gao; Qiuping Wang; Jun Hu; Ling Wang; Zebin Zhou; Bing Liu; Deming Tan; Yang Guan; Haizhen Zhu
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-10       Impact factor: 11.205

4.  Hepatitis B Virus DNA Integration Occurs Early in the Viral Life Cycle in an In Vitro Infection Model via Sodium Taurocholate Cotransporting Polypeptide-Dependent Uptake of Enveloped Virus Particles.

Authors:  Thomas Tu; Magdalena A Budzinska; Florian W R Vondran; Nicholas A Shackel; Stephan Urban
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

Review 5.  Hepatitis B virus cccDNA: Formation, regulation and therapeutic potential.

Authors:  Yuchen Xia; Haitao Guo
Journal:  Antiviral Res       Date:  2020-05-22       Impact factor: 5.970

6.  Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor.

Authors:  Adrien Decorsière; Henrik Mueller; Pieter C van Breugel; Fabien Abdul; Laetitia Gerossier; Rudolf K Beran; Christine M Livingston; Congrong Niu; Simon P Fletcher; Olivier Hantz; Michel Strubin
Journal:  Nature       Date:  2016-03-17       Impact factor: 49.962

7.  Hepatitis B Virus Deregulates the Cell Cycle To Promote Viral Replication and a Premalignant Phenotype.

Authors:  Yuchen Xia; Xiaoming Cheng; Yao Li; Kristin Valdez; Weiping Chen; T Jake Liang
Journal:  J Virol       Date:  2018-09-12       Impact factor: 5.103

Review 8.  Technical standards for hepatitis B virus X protein (HBx) research.

Authors:  Betty L Slagle; Ourania M Andrisani; Michael J Bouchard; Caroline G L Lee; J-H James Ou; Aleem Siddiqui
Journal:  Hepatology       Date:  2015-03-09       Impact factor: 17.425

Review 9.  Revisiting Hepatitis B Virus: Challenges of Curative Therapies.

Authors:  Jianming Hu; Ulrike Protzer; Aleem Siddiqui
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

10.  Proteomic analysis of primary duck hepatocytes infected with duck hepatitis B virus.

Authors:  Yanfeng Zhao; Haijing Ben; Su Qu; Xinwen Zhou; Liang Yan; Bin Xu; Shuangcheng Zhou; Qiang Lou; Rong Ye; Tianlun Zhou; Pengyuan Yang; Di Qu
Journal:  Proteome Sci       Date:  2010-06-07       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.